We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+6.07%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$905M
AUM Growth
-$6.65M
Cap. Flow
+$9.3M
Cap. Flow %
1.03%
Top 10 Hldgs %
52.46%
Holding
657
New
198
Increased
119
Reduced
86
Closed
223

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$67.4M
2
PFE icon
Pfizer
PFE
+$65.6M
3
APTV icon
Aptiv
APTV
+$29.7M
4
MRNA icon
Moderna
MRNA
+$22.6M
5
CRM icon
Salesforce
CRM
+$19.6M

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$85.2M
2
RUN icon
Sunrun
RUN
+$64.1M
3
TPIC
TPI Composites
TPIC
+$31.4M
4
MSFT icon
Microsoft
MSFT
+$30.9M
5
AMZN icon
Amazon
AMZN
+$30.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 28.6%
2 Healthcare 14.17%
3 Technology 11.37%
4 Financials 4.47%
5 Communication Services 3.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRFT
626
DELISTED
Perficient Inc
PRFT
-6,337
Closed -$510K
SWN
627
DELISTED
Southwestern Energy Company
SWN
-48,170
Closed -$273K
MORF
628
DELISTED
Morphic Holding, Inc. Common Stock
MORF
-4,626
Closed -$265K
LBAI
629
DELISTED
Lakeland Bancorp Inc
LBAI
-13,558
Closed -$237K
CBD
630
DELISTED
Companhia Brasileira de Distribuicao
CBD
-61,919
Closed -$482K
CPE
631
DELISTED
Callon Petroleum Company
CPE
-4,529
Closed -$261K
EXPR
632
DELISTED
Express, Inc.
EXPR
-583
Closed -$76K
MDRX
633
DELISTED
Veradigm Inc. Common Stock
MDRX
-23,740
Closed -$439K
CHS
634
DELISTED
Chicos FAS, Inc.
CHS
-60,161
Closed -$396K
NXGN
635
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
-11,799
Closed -$196K
AVID
636
DELISTED
Avid Technology Inc
AVID
-6,743
Closed -$264K
WWE
637
DELISTED
World Wrestling Entertainment
WWE
-5,421
Closed -$314K
AMRS
638
DELISTED
Amyris Inc.
AMRS
-19,152
Closed -$314K
KBAL
639
DELISTED
Kimball International
KBAL
-13,078
Closed -$172K
AUD
640
DELISTED
Audacy, Inc.
AUD
-29,389
Closed -$127K
CSII
641
DELISTED
Cardiovascular Systems, Inc.
CSII
-5,589
Closed -$238K
TEN
642
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
-29,614
Closed -$572K
TPTX
643
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
-4,931
Closed -$385K
PSB
644
DELISTED
PS Business Parks, Inc.
PSB
-1,814
Closed -$269K
TVTY
645
DELISTED
Tivity Health, Inc. Common Stock
TVTY
-16,687
Closed -$439K
PPD
646
DELISTED
PPD, Inc. Common Stock
PPD
-6,363
Closed -$293K
RPAI
647
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
-15,236
Closed -$174K
CSOD
648
DELISTED
Cornerstone OnDemand, Inc.
CSOD
-11,517
Closed -$594K
KIN
649
DELISTED
Kindred Biosciences, Inc.
KIN
-11,713
Closed -$107K
PRAH
650
DELISTED
PRA Health Sciences, Inc.
PRAH
-8,025
Closed -$1.33M

Similar funds

Caxton Associates (New York)'s Q3 2021 Portfolio in Review

As of Q3 2021, Caxton Associates (New York) held 657 positions worth $905M, down 0.73% from $912M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Caxton Associates (New York)'s Q3 2021 filing shows 198 new, 119 increased, 86 reduced and 223 closed positions. Its largest new stake was Pfizer: 1,480,000 shares worth $63.7M. The largest sale was Baidu, an estimated $85.2M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 29% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.

  • Caxton Associates (New York)'s largest Q3 2021 buy was Pfizer: 1,480,000 shares worth $63.7M.
  • Caxton Associates (New York) added most to Tesla in Q3 2021, an estimated $67.4M increase.
  • Caxton Associates (New York)'s biggest Q3 2021 reduction was Sunrun, cutting an estimated $64.1M.
  • Caxton Associates (New York) fully exited Baidu in Q3 2021, selling an estimated $85.2M.
  • Caxton Associates (New York)'s ten largest holdings make up 52% of its $905M portfolio in Q3 2021.
  • Caxton Associates (New York) opened 198 new positions and closed 223 in Q3 2021.
  • Caxton Associates (New York)'s portfolio value fell 0.73% quarter-over-quarter to $905M.

Based on Caxton Associates (New York)'s 13F filing for Q3 2021, filed 15 Nov 2021.